Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | F12 | P00748 | 1/20 | 0.40 |
| ▸ | F7 | P08709 | 1/20 | 0.40 |
| ▸ | F3 | P13726 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108144 | 0.76 | AKT1 (0.54) | AKT1F2F10F12F7 | |
| SCHEMBL18519275 | 0.75 | ALDH1A1 (0.43) | PKMALDH1A1CES2CES1KMT2A | |
| SCHEMBL13570230 | 0.74 | ALDH1A1 (0.33) | AKT1PKMALDH1A1TSHRKMT2A | |
| SCHEMBL58595 | 0.74 | ALDH1A1 (0.54) | AKT1F2BLMALDH1A1CES2 | |
| SCHEMBL7854362 | 0.74 | AKT1 (0.41) | AKT1ALDH1A1CES2CES1TSHR | |
| SCHEMBL10430318 | 0.74 | AKT1 (0.41) | AKT1F2F10F12F7 | |
| SCHEMBL24711143 | 0.73 | PARP1 (0.47) | ALDH1A1KMT2ATDP1MEN1MAPT | |
| SCHEMBL20467598 | 0.73 | CES2 (0.50) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL3848082 | 0.72 | ALDH1A1 (0.42) | AKT1ALDH1A1CES2CES1TSHR | |
| Butadiene SCHEMBL3389124 | 0.72 | AKT1 (0.50) | AKT1F2F10F12F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230403927-A1 | AROMATIC COMPOUNDS | UDC IRELAND LTD (IE) | 2023-12-14 | — | — | US | disclosed |
| US-11800787-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-20230276693-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND MIXTURE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230200102-A1 | MIXED LAYER, METHOD OF PREPARING THE MIXED LAYER, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| WO-2023009475-A1 | ROCK2 INHIBITORS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-02-02 | — | — | WO | disclosed |
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
| WO-2020139962-A1 | HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3 | GLYCOMIMETICS, INC. (US) | 2020-07-02 | — | — | WO | disclosed |
| US-20190233442-A1 | SELECTIVE ESTROGEN RECEPTOR DOWN-REGULATORS (SERDS) | XAVIER UNIVERSITY OF LOUISIANA | 2019-08-01 | — | — | US | disclosed |
| US-20170141329-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2017-05-18 | — | — | US | disclosed |
| CN-105164183-A | Metal nanoparticle-protecting polymer and metal colloidal solution, and method for producing same | DAINIPPON INK & CHEMICALS | 2015-12-16 | — | — | CN | disclosed |
| WO-2011019156-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2011-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, ITK, TEC | AKT1 1422/4885F2 1142/4885F10 2265/4885 |
| US-20190233442-A1 | SELECTIVE ESTROGEN RECEPTOR DOWN-REGULATORS (SERDS) | ESR1, ESR2, ESRRB | AKT1 1514/4885F2 4841/4885F10 4748/4885 |
| US-20230403927-A1 | AROMATIC COMPOUNDS | TYR, CTCF, MITF | AKT1 4855/4885F2 556/4885F10 1142/4885 |
| US-20170141329-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | AKT1 4815/4885F2 579/4885F10 1221/4885 |
| US-11800787-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | AKT1 4815/4885F2 579/4885F10 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.